Entera Bio GAAP EPS of -$0.13 beats by $0.05, revenue of $0.07M misses by $0.02M

May 12, 2022 8:08 AM ETEntera Bio Ltd. (ENTX)By: Pranav Ghumatkar, SA News Editor
  • Entera Bio press release (NASDAQ:ENTX): Q1 GAAP EPS of -$0.13 beats by $0.05.
  • Revenue of $0.07M (-56.3% Y/Y) misses by $0.02M.
  • As of March 31, 2022, Entera had cash and cash equivalents of $20.1 million, compared to $24.9 million as of December 31, 2021.
  • Entera expects that the current cash is sufficient to fund the operations into the fourth quarter of 2022.

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.